Molecular Mechanisms of Apoptosis Regulation Through IP3 Receptors
Molecular Mechanisms of Apoptosis Regulation Through IP3 Receptors
批准号:
10202508
负责人:
Navid Paknejad
金额:
$4.6万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2023-06-30
关键词:
AdoptedApoptosisApoptoticAutophagocytosisBCL-2 ProteinBCL2 geneBad proteinBindingBinding SitesBioenergeticsCell DeathCell SurvivalCell divisionCell physiologyCellsChronic Lymphocytic LeukemiaComplexCryoelectron MicroscopyDependenceElectrophysiology (science)EnzymesFollicular LymphomaGoalsHumanITPR1 geneImageIn VitroInositolKineticsLigandsMCL1 geneMalignant neoplasm of ovaryMediatingMembraneMitochondriaMolecularMolecular ConformationMultiple MyelomaNecrosisPermeabilityPhysiologicalProcessPublishingRegulationResistanceResolutionRoleSignal TransductionSiteStimulusStructureTestingTherapeuticTherapeutic InterventionTitrationsTrefoilUp-RegulationWorkcancer celldesignin vivo Modellarge cell Diffuse non-Hodgkin&aposs lymphomalung small cell carcinomamigrationmutantnanomolarneoplastic cellparticlepreventreceptorresponsetargeted treatment
中文摘要
项目总结/摘要
肌醇1,4,5-三磷酸受体(IP 3Rs)是非内皮细胞主要的胞内Ca ~(2+)释放通道。
可兴奋细胞IP 3R活性驱动许多细胞过程,包括细胞分裂、迁移、线粒体
生物能量学、自噬、凋亡和坏死。由于其在细胞命运决定中的不同作用,
毫不奇怪,肿瘤细胞可以通过选择和修饰IP 3R介导的
Ca 2+信号网络是这些过程的基础。细胞用来逃避编程的一种机制
细胞死亡是为了增加抗凋亡BCL 2蛋白的表达,包括Bcl-2、Bcl-xL和Mcl-1。之间
BCL 2蛋白在细胞中的各种抗凋亡作用,BCL 2蛋白结合IP 3R并调节Ca 2+动力学。尽管
IP 3R在细胞凋亡中的作用和BCL 2-IP 3R的抗细胞凋亡作用的广泛表征
相互作用,对BCL 2蛋白的IP 3R门控和调节机制的理解很少
在分子水平上。然而,清楚的是,BCL 2-IP 3R相互作用促进细胞存活,以响应
凋亡损伤BCL 2和IP 3R之间的相互作用在增强的线粒体之间节流细胞
通过激活Ca 2+依赖性酶和代谢物的生物能量学,以及通过大的
Ca 2+流入线粒体,导致线粒体Ca 2+过载和外膜透化,
细胞凋亡中的定型步骤。在拟议的工作中,将采用功能和结构方法,
用于建立Ca 2+和IP 3激活IP 3R以及抑制IP 3R的机制理解
高浓度的Ca 2+。此外,通过单通道的研究和解决方案的BCL 2-IP 3R
复杂的结构,由BCL 2蛋白调节IP 3R的机制基础将被开发。工作
将提供一个新的框架,通过它我们可以理解IP 3R介导的细胞死亡,为新的
理解和设计治疗方法。
英文摘要
Project Summary/Abstract
Inositol 1,4,5-trisphosphate receptors (IP3Rs) are the primary intracellular Ca2+ release channels in non-
excitable cells. IP3R activity drives numerous cellular processes including cell division, migration, mitochondrial
bioenergetics, autophagy, apoptosis and necrosis. Due to its diverse roles in cell fate decisions, it is perhaps
unsurprising that tumor cells can gain a selective advantage by co-opting and modifying the IP3R-mediated
Ca2+ signaling networks that underlie these processes. One mechanism that cells use to escape programmed
cell death is to increase expression of anti-apoptotic BCL2 proteins, including Bcl-2, Bcl-xL, and Mcl-1. Among
their various anti-apoptotic roles in cells, BCL2 proteins bind to IP3R and modulate Ca2+ dynamics. Despite
extensive characterization of the role of IP3R in apoptosis and the anti-apoptotic effects of BCL2-IP3R
interactions, mechanistic understanding of IP3R gating and modulation by BCL2 proteins is poorly understood
at the molecular level. It is clear, however, that BCL2-IP3R interactions promote cell survival in response to
apoptotic insult. Interactions between BCL2 and IP3R throttle the cell between enhanced mitochondrial
bioenergetics through activation of Ca2+-dependent enzymes and metabolites, and cell death through large
Ca2+ flux into the mitochondrial, leading to mitochondrial Ca2+ overload and outer membrane permeabilization,
the commitment step in apoptosis. In the proposed work, functional and structural approaches will be
employed to establish a mechanistic understanding of activation of IP3R by Ca2+ and IP3, and inhibition of IP3R
by high Ca2+ concentrations. Furthermore, through single channel studies and solution of a BCL2-IP3R
complex structure, a mechanistic basis for the regulation of IP3R by BCL2 proteins will be developed. The work
will provide a new framework by which we can understand IP3R-mediated cell death, paving the way for new
understanding and the design of therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of Apoptosis Regulation Through IP3 Receptors
-
批准号:10433905
-
项目类别:
-
资助金额:$4.28万
-
财政年份:2019
-
负责人:Navid Paknejad
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: